| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/24/2011 | US20110046087 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110045106 Coffee extract |
| 02/24/2011 | US20110045099 Nutraceutical composition and methods of use |
| 02/24/2011 | US20110045093 Pharmaceutical composition and process comprising vegetable proteolytic enzymes in supramolecular nanoparticles, for the treatment of peyronie's disease, connective tissue diseases and use |
| 02/24/2011 | US20110045087 Porous biocompatible polymer material and methods |
| 02/24/2011 | US20110045084 Light-curable bone growth material for treating dental bone defects |
| 02/24/2011 | US20110045071 Generation of a novel type of anti-inflammatory macrophages for clinical use |
| 02/24/2011 | US20110045062 Formulation |
| 02/24/2011 | US20110045048 Bone graft and scaffolding materials immobilized with type i collagen binding peptides |
| 02/24/2011 | US20110045047 Hemostatic implant |
| 02/24/2011 | US20110045014 Acceleration agent of calcium absorption |
| 02/24/2011 | US20110045003 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044978 Method for treating bone fracture |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044956 Nell-1 enhanced bone mineralization |
| 02/24/2011 | US20110044905 Oxytocin analogues |
| 02/24/2011 | DE102009037551A1 Cyclosporinderivate Cyclosporin derivatives |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2286847A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286804A1 A method of treating degenerative disc disease |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286675A1 Composition for promotion of bone growth and maintenance of bone health |
| 02/23/2011 | EP2286669A1 Flavanones-containing food compositions |
| 02/23/2011 | EP2285783A1 Indazole compounds as ccr1 receptor antagonists |
| 02/23/2011 | EP2285394A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof |
| 02/23/2011 | EP2285372A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/23/2011 | EP2029184B1 Injectable fibrin composition for bone augmentation |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | EP1144459B2 Cross-linked hyaluronic acids and medical uses thereof |
| 02/23/2011 | CN1655802B Bioadhesive directed somatic cell therapy |
| 02/23/2011 | CN101981030A Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101980705A Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979087A Health liquor and preparation method thereof |
| 02/23/2011 | CN101979083A External Chinese medicinal bag for treating scapulohumeral periarthritis |
| 02/23/2011 | CN101979081A Plaster for treating arthritis and hyperosteogeny |
| 02/23/2011 | CN101979075A Externally used Chinese medicament bag for treating cervical spondylosis |
| 02/23/2011 | CN101979074A Traditional Chinese medicine for treating rheumatoid arthritis |
| 02/23/2011 | CN101979071A Medicinal composition for treating osteoporosis and preparation method thereof |
| 02/23/2011 | CN101979036A Medicinal liquor for treating rheumatic arthritis |
| 02/23/2011 | CN101979033A Detoxification and network vessel-freeing capsules |
| 02/23/2011 | CN101979032A Medicament for treating calcaneus spur hyperplasia |
| 02/23/2011 | CN101979024A Medicament for treating heart and cerebrovascular diseases, intervertebral disc herniation, cervical spondylosis or hemiplegia |
| 02/23/2011 | CN101979011A Traditional Chinese medicinal transdermal gel ointment for treating cervical spondylosis and preparation method thereof |
| 02/23/2011 | CN101978982A Application of Japanese ginseng or extract thereof to preparation of medicament for resisting gout and repairing hyperuricemic kidney injury |
| 02/23/2011 | CN101978960A Application of naphthalimide derivative as immunosuppressant |
| 02/23/2011 | CN101978957A Glucosamine hydrochloride capsule preparation and preparation method thereof |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893242 Oligonucleotide compositions and their use to induce apoptosis |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893112 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | CA2601515C Compounds having immunomodulator activity |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2447712C Herbal drug composition for cartilage protection |
| 02/22/2011 | CA2411818C Cyclopentabenzofuran compounds and uses thereof |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/17/2011 | WO2011019867A2 Dietary supplements and methods for treating pain and inflammation |
| 02/17/2011 | WO2011019413A1 Pharmaceutical composition and administrations thereof |
| 02/17/2011 | WO2011019153A2 Composition for preventing or treating arthritis, containing an extract of an herbal medicine mixture of schisandra chinensis baillon, scutellaria baicalensis and kalopanax pictus nakai as an active ingredient |
| 02/17/2011 | WO2011019074A1 Nucleic acid that controls fibrosis of cells or organs |
| 02/17/2011 | WO2011018902A1 Pharmaceutical composition for suppressing pain |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | US20110040144 Method and apparatus for weight control by olfactory nerve ablation |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039913 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression |
| 02/17/2011 | US20110039889 Compounds |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039862 Protease Inhibitors |
| 02/17/2011 | US20110039859 Susceptibility to bone damage |
| 02/17/2011 | US20110039855 Tetrahydrocyclopenta[b]indole Androgen Receptor Modulators |
| 02/17/2011 | US20110039835 Substituted arylamide diazepinopyrimidone derivatives |
| 02/17/2011 | US20110039822 Heterocyclic janus kinase 3 inhibitors |
| 02/17/2011 | US20110039819 Substituted phenoxybenzamides |
| 02/17/2011 | US20110039813 Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
| 02/17/2011 | US20110039809 Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporisis |
| 02/17/2011 | US20110039791 Acetylcholinesterase (ache)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof |
| 02/17/2011 | US20110039775 Thyroid stimulating hormone fusion proteins |
| 02/17/2011 | US20110039773 BMP Mutants with Decreased Susceptibility to Noggin |
| 02/17/2011 | US20110039764 Therapeutic composition for bone infectious disease |
| 02/17/2011 | US20110038965 Topical formulation and uses thereof |
| 02/17/2011 | US20110038960 Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides |